Basel @ Regulators and a representative from the pharmaceutical industry discussed the increasing acceptance of real-world data (RWD) in regulatory procedures in the EU during a panel discussion at DIA Europe 2025 on Wednesday. They emphasized the importance of RWD in informing decision making for new drug approvals and improving drug safety data collection.Read More
DIA Europe: EU regulators report steady progress in RWD acceptance
